Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Gujarat Themis Biosyn LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:506879 P/E (TTM) :72.91
ISIN Demat:INE942C01045 Div & Yield %:0.21 EPS (TTM) :4.43
Book Value (RS) :24.267589 Market Cap (Rs Cr.):3519.58 Face Value (RS) :1
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.070.010.010.030.12
Long Term Debt-Equity Ratio0.070.000.000.010.04
Current Ratio2.443.133.973.992.63
Fixed Assets2.733.574.114.273.82
Inventory35.9918.9211.3113.0114.99
Debtors5.187.566.905.775.18
Interest Cover Ratio183.06345.91431.3972.1242.71
PBIDTM (%)47.2648.9354.0654.0748.13
PBITM (%)43.7046.8552.3252.1346.22
PBDTM (%)47.0248.8053.9453.3547.05
CPM (%)35.9036.9240.8039.9235.24
APATM (%)32.3434.8439.0737.9833.33
ROCE (%)27.2144.8260.8566.3866.39
RONW (%)21.6933.7645.9250.3553.83

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)